← Back to Search

Behavioural Intervention

Neck Vibration Therapy for Chronic Cough

N/A
Recruiting
Led By Stephanie Misono
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Cough visual analogue scale (VAS): Rating of 30 or greater on a 0-100 cough severity scale
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks
Awards & highlights

Summary

This trial will test whether a vibrating device placed on the neck can help people with chronic cough when no other cause can be found.

Who is the study for?
This trial is for English-speaking adults aged 18-88 who have been coughing for more than 8 weeks and rate their cough severity at 30 or higher on a scale of 0 to 100. Participants must be able to give informed consent and fill out questionnaires by themselves. People with electronic implants, no wifi access, contraindications to the device used in the study, or those currently in speech therapy for cough cannot join.
What is being tested?
The study is examining how non-invasive vibrotactile stimulation (VTS) of the larynx affects people with unexplained chronic cough. Researchers want to see if this treatment can reduce the severity of symptoms.
What are the potential side effects?
While specific side effects are not listed, VTS is generally considered safe but may potentially cause discomfort at the site of stimulation or an increase in coughing during adjustment to the device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My cough severity is rated 30 or higher on a scale of 0-100.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assess usability of VTS device
Impact of VTS on cough symptoms

Trial Design

1Treatment groups
Experimental Treatment
Group I: Vibrotactile StimulationExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vibrotactile Stimulation
2016
N/A
~10

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,413 Previous Clinical Trials
1,561,353 Total Patients Enrolled
Stephanie MisonoPrincipal InvestigatorUniversity of Minnesota
~0 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top